These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9427927)

  • 41. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery.
    Saha SP; Muluk S; Schenk W; Burks SG; Grigorian A; Ploder B; Presch I; Pavlova BG; Hantak E
    Ann Vasc Surg; 2011 Aug; 25(6):813-22. PubMed ID: 21514114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alcohol pretreatment of small-diameter expanded polytetrafluoroethylene grafts: quantitative analysis of graft healing characteristics in the rat abdominal aorta interposition model.
    Pektok E; Cikirikcioglu M; Tille JC; Kalangos A; Walpoth BH
    Artif Organs; 2009 Jul; 33(7):532-7. PubMed ID: 19566729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
    Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
    J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of femorocrural bypasses performed with modified heparin-bonded expanded polytetrafluorethylene grafts and those with great saphenous vein grafts to treat critical limb ischemia.
    Gessaroli M; Tarantini S; Leone M; Fabbri E; Panzini I
    Ann Vasc Surg; 2015 Aug; 29(6):1255-64. PubMed ID: 26025478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental noninferiority trial of synthetic small-caliber biodegradable versus stable vascular grafts.
    Mugnai D; Tille JC; Mrówczyński W; de Valence S; Montet X; Möller M; Walpoth BH
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):400-7.e1. PubMed ID: 23098749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results with heparin bonded polytetrafluoroethylene grafts for femorodistal bypasses.
    Peeters P; Verbist J; Deloose K; Bosiers M
    J Cardiovasc Surg (Torino); 2006 Aug; 47(4):407-13. PubMed ID: 16953160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced thrombogenic characteristics of expanded polytetrafluoroethylene and polyurethane arterial grafts after heparin bonding.
    Esquivel CO; Björck CG; Bergentz SE; Bergqvist D; Larsson R; Carson SN; Dougan P; Nilsson B
    Surgery; 1984 Jan; 95(1):102-7. PubMed ID: 6691173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The in vivo characterization of electrospun heparin-bonded polycaprolactone in small-diameter vascular reconstruction.
    Duan HY; Ye L; Wu X; Guan Q; Yang XF; Han F; Liang N; Wang ZF; Wang ZG
    Vascular; 2015 Aug; 23(4):358-65. PubMed ID: 25208900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparin and small caliber polytetrafluoroethylene grafts in the carotid arteries of rats.
    Barry KJ; Scott RM; Keough EM
    J Microsurg; 1981; 3(2):72-6. PubMed ID: 7345138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patency of a small vessel prosthesis bonded to tissue plasminogen activator and iloprost.
    Greco RS; Kim HC; Donetz AP; Harvey RA
    Ann Vasc Surg; 1995 Mar; 9(2):140-5. PubMed ID: 7540408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors affecting the patency of small-caliber prostheses: Observations in a suitable canine model.
    Jones DN; Rutherford RB; Ikezawa T; Nishikimi N; Ishibashi H; Whitehill TA
    J Vasc Surg; 1991 Oct; 14(4):441-8; discussion 448-51. PubMed ID: 1920641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative evaluation of ibuprofen treatment on thrombogenicity of expanded polytetrafluoroethylene vascular grafts.
    Gloviczki P; Hollier LH; Dewanjee MK; Trastek VF; Kopesky KR; Kaye MP
    Surgery; 1984 Feb; 95(2):160-8. PubMed ID: 6695334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the deployment and healing of thin-walled expanded PTFE stented grafts and covered stents.
    White R; Kopchok G; Zalewski M; Ayres B; Wilson E; de Virgilio C; Donayre C
    Ann Vasc Surg; 1996 Jul; 10(4):336-46. PubMed ID: 8879388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantification of gas denucleation and thrombogenicity of vascular grafts.
    Bensen CV; Vann RD; Koger KE; Klitzman B
    J Biomed Mater Res; 1991 Mar; 25(3):373-86. PubMed ID: 2026642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Experimental studies of vascular replacement in microsurgery].
    Müller GH
    Handchir Mikrochir Plast Chir; 1988 Jul; 20(4):192-4. PubMed ID: 3262563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A compliant Corethane/Dacron composite vascular prosthesis. Comparison with 4-mm ePTFE grafts in a canine model.
    Wilson GJ; MacGregor DC; Klement P; Weber BA; Binnington AG; Pinchuk L
    ASAIO J; 1993; 39(3):M526-31. PubMed ID: 8268591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of external reinforcement on the patency of infrainguinal polytetrafluoroethylene arterial grafts.
    Sullivan TM; Dunn MM
    J Am Coll Surg; 1996 Mar; 182(3):211-4. PubMed ID: 8603239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model.
    Walpoth BH; Zammaretti P; Cikirikcioglu M; Khabiri E; Djebaili MK; Pache JC; Tille JC; Aggoun Y; Morel D; Kalangos A; Hubbell JA; Zisch AH
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1163-70. PubMed ID: 17467424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.